Collagen V plays a major regulatory role in the formation of heterotypic fibers of the dermis and cartilaginous tissues as well as in the assembly of extracellular matrix.
Introduction
Mutations in genes coding for extracellular matrix proteins cause a variety of connective tissue abnormalities. Mutations in collagens (Col), the most abundant and widely distributed matrix macromolecules, can lead to alterations in fibrillogenesis. The concept that collagen fibrils may be formed by the association of products encoded by more than one collagen gene is not new, as the presence of heterotypic collagen fibrils formed by collagen I/V and collagen V/XI fibrils have been described (1, 2) . It is also known that formation of heterotypic collagen fibers in F1 mice, which are obtained by breeding pN/pN with TSKI/+ mice. Our results show that F1 progeny neither develop cutaneous hyperplasia nor produce anti-topoisomerase I autoantibodies, unlike TSK/ + mice. The diameter of the collagen fibrils in the skin is also comparable to that found in control mice. Thus, the phenotypic changes observed in the TSK mouse could be reversed by genetic complementation with a collagen V-defective mouse.
the diameter of the heterotypic Col I/V fibrils is determined by the ratio of the two collagens that participate in the formation of these fibrils, which suggests that ColV plays a regulatory role in fibrillogenesis (3) . The pN/pN mouse, which is obtained by a targeted deletion in the ColV a2 gene, exhibit skin fragility, skeletal abnormalities, and alterations in the collagen fiber organization, which confirm the regulatory role of ColV (4) . The tight-skin mouse (TSK), a naturally occurring mutant, develops a generalized connective tissue abnormality that is transmitted as an autosomal dominant trait. The TSK mouse phenotype is characterized by marked hyperplasia of loose connective tissue, thickening of the skin, and development of abnormalities in several internal organs (5-7). The skin thickening in TSK mice results from an excessive accumulation of extracellular matrix proteins, such as Col I, Col III, and glycoaminoglycans (5, (8) (9) (10) (11) . More recently, it has been shown that the TSK mouse abnormality is due to a defect in the gene coding for fibrillin-1 (Fbnl) (12, 13) , major component of the microfibrils present in the extracellular matrix. The relationship between the defect in the Fbnl gene and the accumulation of other extracellular proteins that are neither structurally nor functionally associated is not known.
Although there are striking differences between the two strains in cellular infiltration in dermis, both strains exhibit cutaneous thickening due to accumulation of collagen in the skin. This observation prompted us to investigate whether the phenotypic changes observed in the TSK mouse can be reversed by genetic complementation with a collagen-defective strain such as the pN/pN mouse. In this report, we show that the normal phenotype can be restored in F1 TSK/+ mutants with pN/ + genotype.
Materials and Methods
Mice C57BL/6, 129/Sv, C57BL/6 pa/pa, and TSK/+ mice were purchased from the Jackson Laboratory (Bar Harbor, ME), and pN/pN mice were kindly provided by F. Ramirez (Brookdale Center, Mount Sinai School of Medicine). F1 mice were prepared at Mount Sinai Animal Facilities.
Identification of TSK mutants Genomic DNAs were prepared from tail biopsies following the procedure previously described (14) . Ten micrograms of genomic DNA sample was digested with EcoRI and BamHI, Southern blotted, and hybridized with 32P-labeled Fbnl polymorphic DNA probe. The mice exhibiting restriction fragment length polymorphism (RFLP) were identified as previously described (13) .
Light and electron microscopy Skin samples of 4.0 cm2 were removed from the dorsal side immnediately below the neck in a manner that minimized stress. The samples were fixed for 16 h in buffered saline containing formalin, cut into 2-to 3-mm-wide longitudinal strips, dehydrated, and embedded in paraffin according to routine histological methods. The thickness of the skin was determined by measuring it from the top of granular layer to the junction between the dermis and subcutaneous fat on hematoxylin and eosinstained sections. Skin tissues for electron microscopy were processed following standard techniques, and the diameter of collagen fibrils present in various zones of mid-dermis was determined as previously described (15) .
Quantitation of soluble type I collagen in skin The content of soluble ColI and ColV in skin samples was determined as previously described (10) . Briefly, skin samples from 12-to 15-weekold mice were minced and the soluble proteins were extracted with neutral pH salt buffer at 40C and dialyzed against 0.5 M acetic acid buffer. The samples were spun at 10 K for 10 min. The supernatants were digested with pepsin (protein: pepsin, 10:1) and then lyophilized. Both digested and undigested samples were resuspended in SDS-PAGE sample buffer, separated on 4-20% SDS polyacrylamide gradient gels, and stained with silver stain following the manufacturer's protocol (Bio-Rad). The concentration of collagens was determined by scanning the gel using Adobe Photoshop software and ImageQuant software.
Quantitation of anti-topo I autoantibodies
The antibody titer of the sera from 12-to 15-week-old mice was determined by radioimmunoassay (RIA) and the concentration was calculated by integrating the bound cpm value of sera on the linear region of a standard curve constructed with 3-fold dilutions of monoclonal anti-topo I antibody as previously described (16) .
Results and Discussion
Of 18 F1 mice that we studied, five exhibited Fbnl RFLP typical of TSK/+ mice, nine were of wild type, and four were unidentified (Fig. 1) . Histologically, TSK/ + mice exhibit cutaneous hyperplasia characterized by a progressive increase in the deposition of collagenous material that replaces the superficial and deep dermis, extending around adnexa and the panniculus carnosus with some inflammatory cellular infiltration ( Fig. 2A) . On the other hand, pN/pN mice showed thinner epidermis and a thickened dermis containing larger-diameter collagen fibrils without cellular infiltration (Fig. 2B) . The collagen fibrils were less tightly packed and the space between collagen fibrils was filled with proteoglycans (Fig. 3B) (Fig. 3C, D) . Histometric analysis of collagen fibrils present in various zones of dermis showed a preponderance of 30-to 80-nm diameter fibrils in TSK mice, in contrast to that of >110-nm diameter fibrils in pN/pN mice (Fig. 4) . Presence indication of ongoing collagen synthesis (4) . On the other hand, both TSK/ + pN/ + and + / + pN/ + mice (F1) showed principally 80-to 1 10-nm diameter fibrils as in control C57BL/6 pa/pa mice (15) . Thus, there were no histological or ultrastructural abnormalities observed in the collagen fibrils of TSK/+, pN/+ mouse skin. Soluble ColI and ColV content in the skin of F1 mice was also significantly (p < 0.05) lower than that of TSK/+ mice (Table 1) , which shows restoration of normal skin thickness. Our study provides further evidence suggesting that ColV plays an important role in the formation of extracellular matrix in vivo and demonstrates for the first time that mutant ColV protein contributes to rescue of the normal skin phenotype in TSK mice. The mechanisms that might be involved in this process are complex. Although the deletion of ColV a2 N-terminal peptide does Although our current study focused on the alterations exhibited in the skin of these mice, because TSK mice also exhibit cardiac hypertrophy (7) and pulmonary emphysema (6) mentation with a strain having a mutation in the a2 ColV gene. Second, the presence of 50% abnormal ColV fibrils in F1 mice can significantly alter fibrillogenesis or the fiber formation.
